(Q42709984)

5 November 2017

PARP inhibitors in cancer therapy: promise, progress, and puzzles (English)

1 reference

5 November 2017

Leif W Ellisen

1

1 reference

5 November 2017

language of work or name

1 reference

1 February 2011

1 reference

5 November 2017

1 reference

5 November 2017

19

1 reference

5 November 2017

2

1 reference

5 November 2017

165-167

1 reference

Iniparib plus chemotherapy in metastatic triple-negative breast cancer

5 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070420

miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070420

Triple-Negative Breast Cancer

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070420

Poly(ADP-ribose) polymerase inhibitors as promising cancer therapeutics

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070420

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070420

The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070420

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070420

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070420

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3070420

10.1016/J.CCR.2011.01.047

27 May 2018

Identifiers

DOI

1 reference

release_bnez3fuklne4hcmtozhqjy2vv4

5 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bnez3fuklne4hcmtozhqjy2vv4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

5 November 2017

PubMed publication ID

21316599

1 reference